Gam Holding Ag Bristol Myers Squibb CO Transaction History

Gam Holding Ag

$1.14 Billion
Q3 2024

A detailed history of Gam Holding Ag transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Gam Holding Ag holds 242,009 shares of BMY stock, worth $13.8 Million. This represents 1.1% of its overall portfolio holdings.

Number of Shares

242,009

Previous 240,276 0.72%

Holding current value

$13.8 Million

Previous $9.98 Million 25.51%

% of portfolio

1.1%

Previous 0.82%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	BUY	$39.66 - $51.75 $68,730 - $89,682	1,733 Added 0.72%	242,009 $12.5 Million
Q2 2024 Jul 26, 2024	BUY	$40.25 - $52.99 $397,146 - $522,852	9,867 Added 4.28%	240,276 $9.98 Million
Q1 2024 May 13, 2024	SELL	$47.98 - $54.4 $355,243 - $402,777	-7,404 Reduced 3.11%	230,409 $12.5 Million
Q4 2023 Jan 23, 2024	BUY	$48.48 - $57.85 $6.17 Million - $7.37 Million	127,363 Added 115.31%	237,813 $12.2 Million
Q3 2023 Oct 16, 2023	BUY	$57.89 - $64.73 $1,910 - $2,136	33 Added 0.03%	110,450 $6.41 Million
Q2 2023 Jul 27, 2023	SELL	$63.71 - $70.74 $5,797 - $6,437	-91 Reduced 0.08%	110,417 $7.06 Million
Q1 2023 May 09, 2023	BUY	$65.71 - $74.53 $73,463 - $83,324	1,118 Added 1.02%	110,508 $7.66 Million
Q4 2022 Feb 02, 2023	SELL	$68.48 - $81.09 $60,193 - $71,278	-879 Reduced 0.8%	109,390 $7.87 Million
Q3 2022 Oct 19, 2022	SELL	$0.13 - $76.84 $13,665 - $8.08 Million	-105,117 Reduced 48.8%	110,269 $7.84 Million
Q2 2022 Jul 21, 2022	SELL	$72.62 - $79.98 $726,708 - $800,359	-10,007 Reduced 4.44%	215,386 $16.6 Million
Q1 2022 May 06, 2022	BUY	$61.48 - $73.72 $1.09 Million - $1.31 Million	17,732 Added 8.54%	225,393 $16.5 Million
Q4 2021 Jan 26, 2022	SELL	$53.63 - $62.52 $36,253 - $42,263	-676 Reduced 0.32%	207,661 $12.9 Million
Q3 2021 Nov 12, 2021	BUY	$59.17 - $69.31 $769 - $901	13 Added 0.01%	208,337 $12.3 Million
Q2 2021 Aug 09, 2021	SELL	$61.91 - $67.42 $1.5 Million - $1.64 Million	-24,259 Reduced 10.43%	208,324 $13.9 Million
Q1 2021 May 10, 2021	BUY	$59.34 - $66.74 $6.31 Million - $7.1 Million	106,419 Added 84.35%	232,583 $14.7 Million
Q4 2020 Feb 10, 2021	SELL	$57.74 - $65.43 $13.9 Million - $15.8 Million	-241,216 Reduced 65.66%	126,164 $7.83 Million
Q3 2020 Nov 06, 2020	SELL	$57.43 - $63.64 $7,351 - $8,145	-128 Reduced 0.03%	367,380 $22.1 Million
Q2 2020 Aug 10, 2020	SELL	$54.82 - $64.09 $519,474 - $607,316	-9,476 Reduced 2.51%	367,508 $21.6 Million
Q1 2020 May 12, 2020	SELL	$46.4 - $67.43 $1.91 Million - $2.77 Million	-41,080 Reduced 9.83%	376,984 $21 Million
Q4 2019 Feb 06, 2020	BUY	$49.21 - $64.19 $7.31 Million - $9.53 Million	148,510 Added 55.09%	418,064 $26.8 Million
Q3 2019 Nov 08, 2019	SELL	$42.77 - $50.71 $162,526 - $192,698	-3,800 Reduced 1.39%	269,554 $13.7 Million
Q2 2019 Aug 12, 2019	BUY	$44.62 - $49.34 $197,934 - $218,872	4,436 Added 1.65%	273,354 $12.4 Million
Q1 2019 May 10, 2019	BUY	$45.12 - $53.8 $3.86 Million - $4.61 Million	85,598 Added 46.69%	268,918 $12.8 Million
Q4 2018 Feb 08, 2019	SELL	$48.76 - $63.23 $960,913 - $1.25 Million	-19,707 Reduced 9.71%	183,320 $9.53 Million
Q3 2018 Nov 13, 2018	BUY	$55.19 - $62.25 $716,421 - $808,067	12,981 Added 6.83%	203,027 $12.6 Million
Q2 2018 Aug 09, 2018	BUY	$50.53 - $62.98 $1.42 Million - $1.76 Million	28,018 Added 17.29%	190,046 $10.5 Million
Q1 2018 May 15, 2018	SELL	$59.92 - $68.98 $1.18 Million - $1.36 Million	-19,741 Reduced 10.86%	162,028 $10.2 Million
Q4 2017 Feb 14, 2018	BUY	$59.94 - $65.35 $2.04 Million - $2.22 Million	34,019 Added 23.02%	181,769 $11.1 Million
Q3 2017 Nov 14, 2017	SELL	$55.23 - $63.74 $12.8 Million - $14.7 Million	-231,198 Reduced 61.01%	147,750 $9.42 Million
Q2 2017 Aug 07, 2017	BUY	N/A	378,948	378,948 $21.1 Million

Others Institutions Holding BMY

# of Institutions

2,537

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $121B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gam Holding Ag, based on Form 13F filings with the SEC.

News

Stay updated on Gam Holding Ag with notifications on news.

Account